NO940227D0 - Fremgangsmaate for fremstilling av mellomprodukter for syntese av chirale tiazolidin-2,4-dion-derivater - Google Patents
Fremgangsmaate for fremstilling av mellomprodukter for syntese av chirale tiazolidin-2,4-dion-derivaterInfo
- Publication number
- NO940227D0 NO940227D0 NO940227A NO940227A NO940227D0 NO 940227 D0 NO940227 D0 NO 940227D0 NO 940227 A NO940227 A NO 940227A NO 940227 A NO940227 A NO 940227A NO 940227 D0 NO940227 D0 NO 940227D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- intermediates
- synthesis
- dione derivatives
- thiazolidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73356491A | 1991-07-22 | 1991-07-22 | |
| PCT/US1992/005433 WO1993002060A1 (en) | 1991-07-22 | 1992-07-01 | Process for the preparation of intermediates in the synthesis of chiral thiazolidine-2,4-dione derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO940227L NO940227L (no) | 1994-01-21 |
| NO940227D0 true NO940227D0 (no) | 1994-01-21 |
Family
ID=24948157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO940227A NO940227D0 (no) | 1991-07-22 | 1994-01-21 | Fremgangsmaate for fremstilling av mellomprodukter for syntese av chirale tiazolidin-2,4-dion-derivater |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5512689A (no) |
| EP (1) | EP0595868B1 (no) |
| JP (1) | JP2671962B2 (no) |
| AT (1) | ATE173728T1 (no) |
| AU (1) | AU660701B2 (no) |
| CA (1) | CA2111445C (no) |
| DE (1) | DE69227689T2 (no) |
| DK (1) | DK0595868T3 (no) |
| ES (1) | ES2123562T3 (no) |
| FI (1) | FI940306L (no) |
| HU (1) | HUT70412A (no) |
| IE (1) | IE922359A1 (no) |
| IL (1) | IL102574A (no) |
| MX (1) | MX9204278A (no) |
| MY (1) | MY131277A (no) |
| NO (1) | NO940227D0 (no) |
| NZ (1) | NZ243651A (no) |
| PT (1) | PT100710B (no) |
| TW (1) | TW199891B (no) |
| WO (1) | WO1993002060A1 (no) |
| ZA (1) | ZA925469B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5576442A (en) * | 1991-07-22 | 1996-11-19 | Pfizer Inc. | Process and chiral intermediates for thiazole antidiabetics |
| FR2699172B1 (fr) * | 1992-12-11 | 1995-01-20 | Adir | Nouveaux dérivés de 4-méthyl-1,3-oxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| TW416958B (en) * | 1993-05-14 | 2001-01-01 | Pfizer | Enantioselective oxazaborolidine catalysts |
| NZ517993A (en) | 1999-08-31 | 2004-03-26 | Incyte San Diego Inc | Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| IL157740A0 (en) | 2001-03-07 | 2004-03-28 | Incyte San Diego Inc | Heterocyclic derivatives and pharmaceutical compositions containing the same |
| US7265139B2 (en) * | 2001-03-08 | 2007-09-04 | Incyte San Diego Inc. | RXR activating molecules |
| CA2340824A1 (en) * | 2001-03-14 | 2002-09-14 | Ibm Canada Limited-Ibm Canada Limitee | Method and system for application behavior analysis |
| WO2003016267A1 (en) * | 2001-08-17 | 2003-02-27 | Incyte San Diego Incorporated | Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia |
| AU2002352706A1 (en) * | 2001-11-15 | 2003-06-10 | Maxia Pharmaceuticals, Inc. | N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases |
| US7196108B2 (en) * | 2002-03-08 | 2007-03-27 | Incyte San Diego Inc. | Bicyclic heterocycles for the treatment of diabetes and other diseases |
| US7102000B2 (en) * | 2002-03-08 | 2006-09-05 | Incyte San Diego Inc. | Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
| US20050014767A1 (en) * | 2003-01-29 | 2005-01-20 | Magnus Pfahl | Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases |
| CN1774246A (zh) * | 2003-04-18 | 2006-05-17 | 因齐特圣迭戈公司 | 用于治疗代谢失调、癌症和其它疾病的取代异色满化合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4943635A (en) * | 1987-08-27 | 1990-07-24 | President & Fellows Of Harvard College | Enantioselective reduction of ketones |
| US5036079A (en) * | 1989-12-07 | 1991-07-30 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
| TW222626B (no) * | 1991-07-22 | 1994-04-21 | Pfizer |
-
1992
- 1992-07-01 AT AT92915192T patent/ATE173728T1/de not_active IP Right Cessation
- 1992-07-01 WO PCT/US1992/005433 patent/WO1993002060A1/en not_active Ceased
- 1992-07-01 DK DK92915192T patent/DK0595868T3/da active
- 1992-07-01 HU HU9400188A patent/HUT70412A/hu unknown
- 1992-07-01 JP JP5502810A patent/JP2671962B2/ja not_active Expired - Fee Related
- 1992-07-01 DE DE69227689T patent/DE69227689T2/de not_active Expired - Fee Related
- 1992-07-01 EP EP92915192A patent/EP0595868B1/en not_active Expired - Lifetime
- 1992-07-01 CA CA002111445A patent/CA2111445C/en not_active Expired - Fee Related
- 1992-07-01 AU AU23062/92A patent/AU660701B2/en not_active Ceased
- 1992-07-01 ES ES92915192T patent/ES2123562T3/es not_active Expired - Lifetime
- 1992-07-01 FI FI940306A patent/FI940306L/fi unknown
- 1992-07-07 TW TW081105396A patent/TW199891B/zh active
- 1992-07-20 PT PT100710A patent/PT100710B/pt not_active IP Right Cessation
- 1992-07-21 MY MYPI92001294A patent/MY131277A/en unknown
- 1992-07-21 NZ NZ243651A patent/NZ243651A/en unknown
- 1992-07-21 ZA ZA925469A patent/ZA925469B/xx unknown
- 1992-07-21 IL IL10257492A patent/IL102574A/en not_active IP Right Cessation
- 1992-07-21 MX MX9204278A patent/MX9204278A/es unknown
- 1992-07-21 IE IE235992A patent/IE922359A1/en not_active IP Right Cessation
-
1994
- 1994-01-21 NO NO940227A patent/NO940227D0/no unknown
-
1995
- 1995-04-05 US US08/417,502 patent/US5512689A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2123562T3 (es) | 1999-01-16 |
| FI940306A7 (fi) | 1994-01-21 |
| HU9400188D0 (en) | 1994-05-30 |
| NO940227L (no) | 1994-01-21 |
| FI940306A0 (fi) | 1994-01-21 |
| NZ243651A (en) | 1994-01-26 |
| DK0595868T3 (da) | 1999-08-09 |
| TW199891B (no) | 1993-02-11 |
| PT100710A (pt) | 1993-09-30 |
| ATE173728T1 (de) | 1998-12-15 |
| CA2111445C (en) | 1997-02-18 |
| JP2671962B2 (ja) | 1997-11-05 |
| IE922359A1 (en) | 1993-01-27 |
| US5512689A (en) | 1996-04-30 |
| JPH07502017A (ja) | 1995-03-02 |
| CA2111445A1 (en) | 1993-02-04 |
| MX9204278A (es) | 1994-03-31 |
| EP0595868A1 (en) | 1994-05-11 |
| HUT70412A (en) | 1995-10-30 |
| DE69227689D1 (de) | 1999-01-07 |
| AU2306292A (en) | 1993-02-23 |
| FI940306L (fi) | 1994-01-21 |
| AU660701B2 (en) | 1995-07-06 |
| PT100710B (pt) | 1999-07-30 |
| IL102574A (en) | 1996-07-23 |
| WO1993002060A1 (en) | 1993-02-04 |
| IL102574A0 (en) | 1993-01-14 |
| ZA925469B (en) | 1994-01-21 |
| DE69227689T2 (de) | 1999-04-22 |
| EP0595868B1 (en) | 1998-11-25 |
| MY131277A (en) | 2007-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI912142L (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten 5-(2-((2-aryyli-2-hydroksietyyli)amino)propyyli)-1,3-bentsodioksolijohdannaisten valmistamiseksi | |
| NO940227D0 (no) | Fremgangsmaate for fremstilling av mellomprodukter for syntese av chirale tiazolidin-2,4-dion-derivater | |
| AR038430A2 (es) | Derivados de parahercuamida b | |
| FI102069B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi | |
| FI925737A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten indol-3-yylialkyylipiperatsiinijohdannaisten valmistamiseksi | |
| FI914905L (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten merkaptoasetyyliamidopyrrolo- ja -pyridobentsatsepiinijohdannaisten valmistamiseksi | |
| GR3036305T3 (en) | Chiral methyl phenyl oxazolidinones | |
| FI924569A7 (fi) | Menetelmä fenyyli-isoseriinijohdannaisten enantioselektiiviseksi valmi stamiseksi | |
| FI924568A7 (fi) | Menetelmä fenyyli-isoseriinin johdannaisten stereoselektiiviseksi valm istamiseksi | |
| PT87717A (pt) | Process for preparing 2,4-thiazolidinedione derivatives | |
| AU686955B2 (en) | Process to obtain benzoxazines to be used for the synthesis of ofloxazine, levofloxazine and derivatives | |
| FI925260L (fi) | Menetelmä terapeuttisesti käyttökelpoisten 6-amino-substituoitujen oktahydro-1,7,8-indolitsiinitriolijohdannaisten valmistamiseksi | |
| FI906084L (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 5-(2-metyyli-4,4,4-trifluoributyylikarbamoyyli)indolijohdannaisten valmistamiseksi | |
| FI892946A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3,4,5-tetrahydro-1H-3-bentsoatsepiinijohdannaisten valmistamiseksi | |
| NO885100L (no) | Anvendelse av 1,3-butandiolacetoacetat som naeringsmiddel,saerlig for parenteral tilfoersel. | |
| AU651717B2 (en) | Process for the production of methyl acetate | |
| FI910756A7 (fi) | Fermentaatiomenetelmä staurosporiinin valmistamiseksi | |
| HUT63621A (en) | Process for producing new oxazolidine derivatives | |
| FI906324A0 (fi) | Anordning och foerfarande foer foerkromning av artiklar. | |
| EP0250755A3 (en) | Fluorine derivatives of vitamin d3 and process for producing the same | |
| DE69914880D1 (de) | Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate | |
| HK91086A (en) | PROCESS FOR PREPARING 16α-HYDROXY-17α-AMINOPREGNANE DERIVATIVES | |
| JPS5620584A (en) | Novel oxygenncontaining heterocyclic compound | |
| NO980937L (no) | Fremgangsmåte for fremstilling av benzyl-substituerte rhodaninderivater | |
| FI895831A7 (fi) | Menetelmä (d)-6-fluori-2,3-dihydro-2',5'-dioksospiro/4H-1-bentsopyraan i-4,4'-imidatsoliini/-2-karboksamidijohdannaisien valmistamiseksi |